Study of Intensive Care Unit (ICU)-Acquired Weakness (Handgrip Strength Study)

January 15, 2016 updated by: Naeem Ali, MD

Clinical Determinants of Handgrip Strength in Critically Ill Adults: Pilot Study

To better understand ICU-acquired weakness in patients requiring mechanical ventilation in the Intensive Care Unit.

Study Overview

Status

Completed

Detailed Description

We have generated the hypothesis that handgrip strength can be used to develop our understanding of the effects of critical illness on peripheral muscle strength.

To begin to develop this hypothesis, a better understanding of the determinants of handgrip strength needs to be developed. As a result we propose to perform a prospective observational study examining the clinical factors that are associated with handgrip strength. Several clinical factors are known to be associated with increased risk of developing ICUAP while hospitalized: multiple organ failure, severe sepsis, female gender and treatments like steroids. As many of these risk factors are not modifiable, the opportunity to intervene is unclear. However, by attempting to better describe the spectrum of strength deficits experienced by critically ill patients we may better be able to dissect and prevent ICUAP.

Study Type

Observational

Enrollment (Actual)

49

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43210
        • The Ohio State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

subjects requiring prolonged mechanical ventilation in the ICU

Description

Inclusion Criteria:

  • • Adult patients admitted to the Medical ICU

    • Age ≥ 18 years of age at ICU admit.
    • Requiring mechanical ventilation for at least 24 hours

Exclusion Criteria:

  • • Moribund or in the process of withdrawal of life support

    • Patient, family or physicians not in favor of continued support until awakening.
    • Profound neurologic injury associated with little or no chance of awakening.
    • Active consideration of a diagnosis of brain death by treating physicians.
    • Known history of chronic neurological disease resulting in muscle weakness in more than two limbs.
    • Inability to perform handgrip dynamometry prior to acute illness.
    • Subject is a Non-english speaker
    • Subject or surrogate unable to provide informed consent.
    • ICU stay of greater than 24 hours within the last thirty days or at any point during the current hospitalization
    • Greater than seven days of hospital care prior to hospital admission.
    • Greater than five days since inclusion criteria met.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1.
Those with ICU-acquired weakness

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To determine the feasibility of performing serial assessments of strength (handgrip and limb muscle strength) in a broad population of critically ill patients.
Time Frame: duration of ICU stay-up to 10 days
duration of ICU stay-up to 10 days

Secondary Outcome Measures

Outcome Measure
Time Frame
To determine the acute medical illnesses associated with weakness
Time Frame: duration of ICU stay-up to 10 days
duration of ICU stay-up to 10 days
To determine the modifiable risk factors associated with weakness
Time Frame: duration of ICU stay-up to 10 days
duration of ICU stay-up to 10 days
To determine if there is an association between handgrip strength and ICUAP risk
Time Frame: duration of ICU stay-up to 10 days
duration of ICU stay-up to 10 days
To generate a set of normative data for handgrip strength in critically ill patients adjusting for important non-modifiable risk factors
Time Frame: duration of ICU stay-up to 10 days
duration of ICU stay-up to 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Naeem A. Ali, M.D., Ohio State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2008

Primary Completion (Actual)

May 1, 2010

Study Completion (Actual)

May 1, 2010

Study Registration Dates

First Submitted

June 17, 2008

First Submitted That Met QC Criteria

June 18, 2008

First Posted (Estimate)

June 19, 2008

Study Record Updates

Last Update Posted (Estimate)

January 18, 2016

Last Update Submitted That Met QC Criteria

January 15, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2008H0081

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Muscle Strength

Subscribe